FULC R&D Expenses

Fulcrum Therapeutics Inc · R&D Expenses

FULC logo

FULC R&D Expenses

Latest reported$12.44M
FULC Quarterly R&D Expenses ($5.57M → $12.44M)
High-resolution chart · PNG

FULC r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fulcrum Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
12,444,000
14,084,000
15,416,000
14,296,000
12,987,000
13,404,000
11,344,000
14,639,000
17,261,000
19,294,000
18,999,000
18,238,000
17,849,000
16,715,000
18,566,000
15,366,000
25,019,000
17,831,000
18,912,000
17,077,000
17,378,000
16,334,000
16,145,000
15,640,000
12,775,000
14,482,000
11,568,000
13,496,000
10,860,000
34,629,000
6,860,000
6,963,000
5,788,000
5,573,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.